Airway basal cells are essential for the homeostatic maintenance and repair of the respiratory epithelium. Recent study also revealed pronounced regional differences between human proximal and distal airway cell types, including basal cells. UTHealth researchers and their collaborators established a novel strategy to generate region-specific proximal, intermediate, and distal airway basal cells derived from human induced pluripotent stem cells (hiPSCs), leading to new opportunities in regeneration medicine, cell-based therapies, and related disease research.
Background
Significance and Impact
Traditionally, basal cells were considered to be homogenous until recent studies revealed key evidence for basal cell heterogeneity in the airways of the lung. These differences include variations in lineage abundance, molecular phenotypes, and functions of each cell type in both homeostasis and repair. UTHealth researchers and their collaborator at MDACC established a new strategy to generate region-specific proximal, intermediate, and distal airway basal cells from hiPSCs. The availability of human iPSC-derived region-specific airway basal stem cells opens up significant opportunities for broad applications in regenerative medicine, lung development studies, and airway disease research.
Benefits/Technology Advantages
Intellectual Property Status
Provisional patent application filed.
Available for licensing.
Selected Publications
Related publications in preparation.
About the Inventors
Sarah Xuelian Huang, Ph.D.
Assistant Professor of Biochemistry and Molecular Biology at UTHealth Houston
Dung-Fang Lee, Ph.D.
Associate Professor of Integrative Biology and Pharmacology at UTHealth Houston